Filing Details
- Accession Number:
- 0001181431-13-044383
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-08-13 16:00:37
- Reporting Period:
- 2013-08-09
- Filing Date:
- 2013-08-13
- Accepted Time:
- 2013-08-13 16:00:37
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1338042 | Aegerion Pharmaceuticals Inc. | AEGR | Pharmaceutical Preparations (2834) | 202960116 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1243004 | D Sandford Smith | C/O Aegerion Pharmaceuticals, Inc. 101 Main Street, Suite 1850 Cambridge MA 02142 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-08-09 | 8,217 | $16.28 | 8,217 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2013-08-09 | 1,783 | $15.00 | 10,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-08-09 | 8,463 | $92.33 | 1,537 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-08-12 | 1,537 | $92.25 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2013-08-09 | 8,217 | $0.00 | 8,217 | $16.28 |
| Common Stock | Stock Option (right to buy) | Disposition | 2013-08-09 | 1,783 | $0.00 | 1,783 | $15.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 16,435 | 2022-01-03 | No | 4 | M | Direct | |
| 11,071 | 2022-06-05 | No | 4 | M | Direct |
Footnotes
- Represents a weighted-average price. These shares were sold in multiple transactions at prices ranging from $92.07 to $92.66, inclusive. For all transactions reported in this Form 4 utilizing a weighted-average price, the reporting person undertakes to provide to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 1 to this Form 4.
- Represents a weighted-average price. These shares were sold in multiple transactions at prices ranging from $92.25 to $92.26, inclusive. For all transactions reported in this Form 4 utilizing a weighted-average price, the reporting person undertakes to provide to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 2 to this Form 4.
- The shares of common stock underlying this stock option award vest in three equal yearly installments starting on January 3, 2013.
- The shares of common stock underlying this stock option award vest in three equal yearly installments starting on June 5, 2013.
Billionaire Hedge Funds
